eicosapentaenoic acid ethyl ester has been researched along with ascorbic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentsen, H; Bøhmer, T; Osnes, K; Refsum, H; Solberg, DK | 1 |
| Bentsen, H; Landrø, NI | 1 |
2 trial(s) available for eicosapentaenoic acid ethyl ester and ascorbic acid
| Article | Year |
|---|---|
A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Ascorbic Acid; Double-Blind Method; Drug Therapy, Combination; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Vitamin E; Vitamins; Young Adult | 2013 |
Neurocognitive effects of an omega-3 fatty acid and vitamins E+C in schizophrenia: A randomised controlled trial.
Topics: Adult; Antipsychotic Agents; Ascorbic Acid; Attention; Eicosapentaenoic Acid; Executive Function; Fatty Acids, Omega-3; Female; Humans; Male; Mental Status and Dementia Tests; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Vitamin E; Young Adult | 2018 |